CDSE "Safety, Value and Innovation" Seminar

Real-world Data, Advanced Analytics, and the Evolution of Postmarket Drug Safety Surveillance

Gerald Dal Pan, MD, MHS

Director, Office of Surveillance & Epidemiology
FDA's Center for Drug Evaluation and Research
February 14, 2022